Gilead Sciences to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14
May 06 2019 - 4:01PM
Business Wire
Webcast Available Through Gilead Corporate
Website
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin
L. Washington, Gilead’s Executive Vice President and Chief
Financial Officer, and John McHutchison, AO, MD, Gilead’s Chief
Scientific Officer and Head of Research & Development, will
participate in a fireside chat at the Bank of America Merrill Lynch
2019 Health Care Conference in Las Vegas on Tuesday, May 14 at
10:00 a.m. Pacific Time.
The audio portion of the fireside chat will be accessible live
through the company’s Investors page at
http://investors.gilead.com/. Please connect to the company’s
website at least 15 minutes prior to the start of the presentation
to ensure adequate time for any software download that may be
required to listen to the webcast. The replay will be available for
14 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190506005628/en/
Sung LeeInvestor Relations(650) 524-7792
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024